Page last updated: 2024-08-23

vindesine and Leukemia L 1210

vindesine has been researched along with Leukemia L 1210 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howard, SM; Sheppard, JR; Theologides, A1
Fox, BW; McGown, AT; Poppitt, DG1
Fox, BW; McGown, AT; Poppitt, DG; Swindell, R1
Bartholeyns, J; Koch-Weser, J1
Anstett, M; Combe-Perez, V; Leonce, S; Pierre, A1
Atassi, G; Bhushana Rao, KS; Collard, MP; Dejonghe, JP; Hannart, JA; Trouet, A1
Hansch, C; Khwaja, TA; Selassie, CD1

Other Studies

7 other study(ies) available for vindesine and Leukemia L 1210

ArticleYear
Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
    Cancer research, 1980, Volume: 40, Issue:8 Pt 1

    Topics: Animals; Cell Division; Isoproterenol; Leukemia L1210; Mice; Mitosis; Prostaglandins E; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Prostaglandin; Structure-Activity Relationship; Vinblastine; Vincristine; Vindesine

1980
Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
    Cancer chemotherapy and pharmacology, 1984, Volume: 13, Issue:1

    Topics: Animals; Cell Line; Cell Survival; Drug Resistance; Gene Amplification; Leukemia L1210; Methotrexate; Mice; Vinblastine; Vinca Alkaloids; Vincristine; Vindesine

1984
The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.
    Cancer chemotherapy and pharmacology, 1984, Volume: 13, Issue:1

    Topics: Animals; Cell Division; Cell Line; Chromosomes; DNA, Neoplasm; Drug Resistance; Flow Cytometry; Leukemia L1210; Methotrexate; Mice; Polyploidy; Vinblastine; Vinca Alkaloids; Vincristine; Vindesine

1984
Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.
    Cancer research, 1981, Volume: 41, Issue:12 Pt 1

    Topics: Animals; Doxorubicin; Drug Therapy, Combination; Eflornithine; Female; Leukemia L1210; Liver Neoplasms, Experimental; Male; Mice; Neoplasms, Experimental; Ornithine; Rats; Vinblastine; Vindesine

1981
Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
    Anti-cancer drugs, 1990, Volume: 1, Issue:2

    Topics: Acridine Orange; Animals; Benzimidazoles; Cell Cycle; Chromatin; Flow Cytometry; Leukemia L1210; Mice; Mitosis; Thymidine; Tumor Cells, Cultured; Vinblastine; Vinca Alkaloids; Vincristine; Vindesine

1990
Vinblastin-23-oyl amino acid derivatives: chemistry, physicochemical data, toxicity, and antitumor activities against P388 and L1210 leukemias.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:8

    Topics: Animals; Antineoplastic Agents, Phytogenic; Female; Lethal Dose 50; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Structure-Activity Relationship; Vinblastine; Vincristine; Vindesine

1985
Structure-activity relationships of antineoplastic agents in multidrug resistance.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:7

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured

1990